Indications for Constitutional Cytogenetic Investigations
·
Peripheral blood:
·
Family history:
·
Chromosome rearrangement
·
Mental retardation of possible
chromosomal origin where it is not possible to study the affected individual
·
Relative with a history of losses, a
malformed fetus, or stillbirth of unknown nature, as clinically indicated
·
Recurrent pregnancy losses, stillbirths,
or neonatal deaths where it is not possible to study the affected conceptus
·
Primary or secondary amenorrhea
·
Premature menopause
·
Azospermia
·
Oligospermia
·
Clinically significant abnormal growth
·
Short stature
·
Excessive growth
·
Microcephaly
·
Macrocephaly
·
Ambiguous genitalia
·
Dysmorphism
·
Congenital anomalies
·
Mental retardation / developmental delay
·
Suspected deletion / microdeletion
/ duplication syndrome
·
X-linked recessive condition in a female
·
Clinical fefatures
of a chromosomal instability syndrome
·
Bone marrow transplantation with an
opposite ssex donor
·
Prenatally diagnosed structural
chromosome abnormality or unusual chromosome variant
·
Infertility of unknown etiology
·
3 or more pregnancy losses (or 2 or more)
·
Clinical features of a syndrome with
cytogenetic findings (ex. Roberts, ICF)
·
History of unexplained stillbirth or
neonatal death
·
Fibroblast:
·
Clinically suspected mosaicism
·
Spontaneous abortions, stillbirths, and
infant deaths:
·
Unexplained (depending on the policies of
the institution)
·
With hydrops fetalis, growth restriction, dysmorphic
features, anomalies
·
Any other condition deemed by a physician
as indicating a need for cytogenetic investigation
·
Prenatal cytogenetic diagnosis when
pathological confirmation is not available
·
Mosaic or unusual prenatal cytogenetic
diagnosis
·
POCs from spontaneous abortion:
·
Recurrent spontaneous abortion
·
While being treated for another cause of
recurrent spontaneous abortion
·
Maternal age 35 years or more
·
After in vitro fertilization, intracytoplasmic sperm injection, etc
·
Pathologic examination suggests possibility
of cytogenetic abnormality
·
References:
·
CCMG Cytogenetic Practice Guidelines
(2003)